Shareholder Information IAS PDRA International Accounting Standards Dechras Product Development and Regulatory Affairs team IFRSs Qualifying LTIP Award International Financial Reporting Standards Qualifying LTIP Awards comprises a CSOP option and an ordinary nil-cost LTIP award, with the ordinary award scaled back at exercise to IT take account of any gain made on exercise of the CSOP option.
Information Technology R&D KPI Research and Development Key Performance Indicator RCF Leverage Revolving Credit Facility The ratio of Net Debt to underlying EBITDA RIDDOR LIBOR Reporting of Injuries, Diseases and Dangerous Occurrences The London Inter-Bank Offered Rate Regulations LTAFR Rights Issue Lost Time Accident Frequency Rate The three for ten rights issue of 20,040,653 shares, details of which are set out in the prospectus of the Company dated 25 April 2012 LTIP Long Term Incentive Plan ROCE Return On Capital Employed MAT Moving Annual Total RPI Retail Price Index MHRA Medicines and Healthcare products Regulatory Agency: an executive SAYE agency of the Department of Health in the UK Save As You Earn Share Scheme Maximum Residue Limit MRL SET The maximum acceptable concentration of a substance that may be Senior Executive Team found in a food product obtained from an animal that has received a veterinary medicine SG&A Selling, General and Administrative Expenses NADA New Animal Drug Application SKUs Stock Keeping Units Non-Executive Directors The Non-Executive Directors of the Company, currently Tony Rice, TSR Julian Heslop, Lawson Macartney and Ishbel Macpherson Total Shareholder Return North America Pharmaceuticals VMD North American Pharmaceuticals Segment comprising DVP US and Veterinary Medicines Directorate Canada and Dechra-Brovel OECD The Organisation for Economic Cooperation and Development Ordinary Shares An ordinary share of 1 pence in the share capital of the Company Oracle Programme Enterprise Resources Planning ERP software POMs Prescription Only Medicines Stock Code: DPH 173 slugline Dechra Annual Report 2017 - Back.
indd 173 04 09 2017 14:01:15 Shareholder Information Financial Calendar Electronic Communications Interim Management Statement 20 October 2017 Shareholders now have the opportunity to receive shareholder 2017 Annual General Meeting 20 October 2017 communications electronically, e. g. Annual Reports, Notice of the Annual General Meeting and Proxy Forms.
You can elect to receive Final Dividend Ex-Dividend Date 26 October 2017 email notifications of shareholder communications by registering at Final Dividend Record Date 27 October 2017 www.
co. uk, where you can also set up a bank mandate Final Dividend Payment Date 17 November 2017 to receive dividends directly to your bank account and to submit proxy votes for shareholder meetings.
Receiving the Companys Annual General Meeting communications electronically allows the Company to communicate The 2017 Annual General Meeting of the Company will be held at with its shareholders in a more environmentally friendly, cost effective 1.00pm on 20 October 2017 at The Mere Golf Resort & Spa, Chester and timely manner.
The notice of meeting the Notice, which includes special business to be transacted at the Annual Registrar General Meeting together with an explanation of the resolutions to be Dechras Registrar is Equiniti Limited.
considered at the meeting, is made available on the Company website Equiniti should be contacted for any matters relating to your or mailed to shareholders, if they have elected to receive the Notice in shareholding, including: paper format.
Notification of change in name and address Share History Dechra floated on the London Stock Exchange in September 2000 at Enquiries about dividend payments 1.20 per share, with a market capitalisation of 60.0 million.
Submission of proxy form for voting at the Annual General Meeting In relation to the acquisition of VetXX Holdings A S, on 15 January Shareholders who receive duplicate sets of Company mailings because 2008, Dechra undertook a placing and open offer on the basis of 11 they have multiple accounts should contact Equiniti to have their Open Offer shares for every 50 existing shares held on 10 December accounts amalgamated.
2007 at an issue price of 303 pence.
Equiniti offers a facility whereby shareholders are able to access their shareholdings in Dechra via their website www.
On 5 April 2012, a Rights Issue was announced on the basis of three new ordinary shares for every existing ten shares held on Alternatively, Equiniti can be contacted at: 23 April 2012 at a subscription price of 3.00 per share.
The Rights Issue resulted in 20,040,653 shares being issued with dealings Equiniti Limited commencing on 16 May 2012.
Aspect House Spencer Road On 17 March 2016 4,398,600 ordinary shares were offered by way of Lancing placing at an issue price of 11.00 per share.
West Sussex BN99 6DA Company Website Registrars Shareholder Helpline for Dechra: 0371 384 2030 or The Dechra website www.
com is the best source of useful 44 0 121 415 7047, if calling from outside of the UK.
and up-to-date information about Dechra and its activities, including Please have your Shareholder Reference Number to hand whenever the latest news, financial and product information to help improve you contact the Registrar: this can be found on your share certificate or understanding of our business.
Additionally, the terms of reference of a recent dividend tax voucher.
all our Committees, Articles of Association, our Values and a number of our internal policies are published on the website.
Share Dealing Service Equiniti Financial Services Limited offer a Share Dealing Service to buy or sell shares.
Further information can be obtained from www.
co. uk dealing or by telephoning 0845 603 7037.
Telephone Internet Postal share share share dealing dealing dealing Fee on value of transaction 1.5% 1.5% 1.75% up to 50,000 Balance over 50,000 0.25% 0.25% 1.75% Minimum charge 60.00 45.00 60.00 Stamp duty charge purchases only 0.5% 0.5% 0.5% Visit us at our website Equiniti Financial Services Limited and its agents are authorised and www.
com regulated by the Financial Conduct Authority.
Please note that the price of shares can go down as well as up, and you are not guaranteed to get back the amount you originally invested.
If you are in any doubt, you should contact an independent financial adviser.
174 Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2017 www.
com slugline Dechra Annual Report 2017 - Back.
